modelScopolamine_AlvarezJimenez2016_reference

Extends from Pharmacolibrary.Pharmacokinetic.Models.PK_1C.

Information

name:scopolamine
ATC code:N05CM05
model:one compartment, IV dosing (PK_1C)
source:Alvarez-Jimenez R et al. 2016
population:healthy subjects
measured compound:scopolamine
review:curated candidate
record page:pharmacolibrary-docs

Parameters as reported in the paper

parametervalueunitmeaning
apparent central and peripheral volume of distribution2.66lV
clearance1.09l min(-1)CL

About scopolamine

Scopolamine is an anticholinergic used for conditions such as motion sickness, iridocyclitis, and other disorders listed in its treatment records. It remains an approved medicine and is included on the WHO essential medicines list, used in ophthalmic, antiemetic, and sedative roles.

Summary written by glm-5.3-flash from Wikidata Q337188 and the WHO ATC classification; not checked by a person.

Identity, molar mass and metabolites: Scopolamine.

References

  1. Alvarez-Jimenez R et al. (2016). Model-based exposure-response analysis to quantify age related differences in the response to scopolamine in healthy subjects. British journal of clinical pharmacology 82(4):1011–1021. DOI:10.1111/bcp.13031 PUBMED:27273555

Parameters

TypeNameDefaultDescription
RealCl_ref1.8166666666666667e-05Cl [m3/s]
RealVd_ref0.00266Vd [m3]
Modelica.Units.SI.Massweight (from PK_1C)75patient weight (kg)
Modelica.Units.SI.SpecificVolumeVdPerKg (from PK_1C)0.0009Volume of distribution per kg (default 0.9 L/kg)
Modelica.Units.SI.MassFractionF (from PK_1C)1bioavailability (0-1)
Pharmacolibrary.Types.ClearanceCl (from PK_1C)2.7777777777777776e-7clearance
Modelica.Units.SI.TimeadminTime (from PK_1C)60first administration time (s)
Modelica.Units.SI.TimeadminDuration (from PK_1C)600administration duration (s)
Modelica.Units.SI.TimeadminPeriod (from PK_1C)8*60*60period of administration (default 8 hours)(s)
Pharmacolibrary.Types.MassadminMass (from PK_1C)1e-4administration mass (mg)
IntegeradminCount (from PK_1C)8number of dose administered (1)
Pharmacolibrary.Types.VolumeVd (from PK_1C)VdPerKg*weightVolume of distribution (m3)
Info › Therapeutic range (metadata, not used in equations)
Pharmacolibrary.Types.MassConcentrationCmin (from PK_1C)0.004minimal therapeutic range
Pharmacolibrary.Types.MassConcentrationCmax (from PK_1C)0.008maximal therapeutic range
Pharmacolibrary.Types.MassConcentrationCtox_peak (from PK_1C)0.012toxicity peak level
Pharmacolibrary.Types.MassConcentrationCtox_trough (from PK_1C)0.006toxicity trough level
Info › Substance metadata
Modelica.Units.SI.MolarMassMM (from PK_1C)0molar mass [kg/mol]; 0 = not supplied (molar concentrations are then 0)
Info › Substance metadata (not used in equations)
Pharmacolibrary.Types.DoseLD50 (from PK_1C)0median lethal dose [mg/kg]; 0 = unknown

Connectors

TypeNameDefaultDescription
Types.ConcentrationOutputC_central (from PK_1C)
Interfaces.ConcentrationPort_bcentralCPort (from PK_1C)

Components

TypeNameDefaultDescription
Pharmacokinetic.NoPerfusedTissueCompartmentcentral (from PK_1C)
Pharmacokinetic.ClearanceDrivenEliminationelim (from PK_1C)
Sources.PeriodicDoseperiodicDose (from PK_1C)
Modelica.Units.SI.Timet1_2 (from PK_1C)central-compartment elimination half-life = ln(2)*Vd/Cl (1-compartment approximation; NOT the terminal half-life of 2-/3-compartment models)

Revisions

  • 10/2026 generated by pharmacolibrary-dev export.pharmacolibrary_models from Alvarez-Jimenez_2016: parameters extracted from the paper by the pharmacolibrary-dev pipeline, model built by its engineer, reviewed: curated candidate